|
🐜
|
Direct comparison of treatment responses, remission rates, and drug adherence in patients with rheumatoid arthritis treated with adalimumab, etanercept, or infliximab: results from eight years of surveillance of clinical practice in the nationwide Danish DANBIO registry.
15 auth.
M. Hetland,
I. Christensen,
U. Tarp,
L. Dreyer,
A. Hansen,
I. Hansen,
G. Kollerup,
L. Linde,
H. Lindegaard,
U. E. Poulsen,
...
A. Schlemmer,
D. Jensen,
S. Jensen,
G. Hostenkamp,
M. Østergaard
|
9 |
2010 |
9
🐜
|
|
🐜
|
MRI bone oedema is the strongest predictor of subsequent radiographic progression in early rheumatoid arthritis. Results from a 2-year randomised controlled trial (CIMESTRA)
24 auth.
M. Hetland,
B. Ejbjerg,
K. Hørslev-Petersen,
S. Jacobsen,
A. Vestergaard,
A. Jurik,
K. Stengaard-Pedersen,
P. Junker,
T. Lottenburger,
I. Hansen,
...
L. Andersen,
U. Tarp,
H. Skjødt,
J. K. Pedersen,
O. Majgaard,
A. Svendsen,
T. Ellingsen,
H. Lindegaard,
A. F. Christensen,
J. Vallo,
T. Torfing,
E. Narvestad,
H. Thomsen,
M. Østergaard
|
8 |
2008 |
8
🐜
|
|
🐜
|
Treatment response, drug survival, and predictors thereof in 764 patients with psoriatic arthritis treated with anti-tumor necrosis factor α therapy: results from the nationwide Danish DANBIO registry.
9 auth.
B. Glintborg,
M. Østergaard,
L. Dreyer,
N. Krogh,
U. Tarp,
M. Hansen,
...
S. Rifbjerg-Madsen,
T. Lorenzen,
M. Hetland
|
7 |
2011 |
7
🐜
|
|
🐜
|
Highest clinical effectiveness of rituximab in autoantibody-positive patients with rheumatoid arthritis and in those for whom no more than one previous TNF antagonist has failed: pooled data from 10 European registries
14 auth.
K. Chatzidionysiou,
E. Lie,
E. Nasonov,
G. Lukina,
M. Hetland,
U. Tarp,
C. Gabay,
P. V. van Riel,
D. Nordström,
J. Gómez-Reino,
...
K. Pavelka,
M. Tomšič,
T. Kvien,
R. V. van Vollenhoven
|
7 |
2011 |
7
🐜
|
|
🐜
|
Radiographic progression and remission rates in early rheumatoid arthritis – MRI bone oedema and anti-CCP predicted radiographic progression in the 5-year extension of the double-blind randomised CIMESTRA trial
19 auth.
M. Hetland,
K. Stengaard-Pedersen,
P. Junker,
M. Østergaard,
B. Ejbjerg,
S. Jacobsen,
T. Lottenburger,
I. Hansen,
U. Tarp,
L. Andersen,
...
A. Svendsen,
J. K. Pedersen,
U. B. Lauridsen,
T. Ellingsen,
H. Lindegaard,
J. Pødenphant,
A. Vestergaard,
A. Jurik,
K. Hørslev-Petersen
|
7 |
2010 |
7
🐜
|
|
🐜
|
Clinical response, drug survival, and predictors thereof among 548 patients with psoriatic arthritis who switched tumor necrosis factor α inhibitor therapy: results from the Danish Nationwide DANBIO Registry.
12 auth.
B. Glintborg,
M. Ostergaard,
N. Krogh,
M. Andersen,
U. Tarp,
A. Loft,
...
H. Lindegaard,
M. Holland-Fischer,
H. Nordin,
D. Jensen,
C. H. Olsen,
M. Hetland
|
7 |
2013 |
7
🐜
|
|
🐜
|
Combination treatment with methotrexate, cyclosporine, and intraarticular betamethasone compared with methotrexate and intraarticular betamethasone in early active rheumatoid arthritis: an investigator-initiated, multicenter, randomized, double-blind, parallel-group, placebo-controlled study.
18 auth.
M. Hetland,
K. Stengaard-Pedersen,
P. Junker,
T. Lottenburger,
T. Ellingsen,
L. Andersen,
I. Hansen,
H. Skjødt,
J. K. Pedersen,
U. B. Lauridsen,
...
A. Svendsen,
U. Tarp,
J. Pødenphant,
G. Hansen,
H. Lindegaard,
Anselmo de Carvalho,
M. Østergaard,
K. Hørslev-Petersen
|
7 |
2006 |
7
🐜
|
|
🐜
|
Incidences of overall and site specific cancers in TNFα inhibitor treated patients with rheumatoid arthritis and other arthritides – a follow-up study from the DANBIO Registry
17 auth.
L. Dreyer,
L. Mellemkjær,
A. Andersen,
P. Bennett,
U. E. Poulsen,
Torkell Juulsgaard Ellingsen,
T. Hansen,
D. Jensen,
L. Linde,
H. Lindegaard,
...
A. Loft,
H. Nordin,
E. Omerovic,
C. Rasmussen,
A. Schlemmer,
U. Tarp,
M. Hetland
|
7 |
2012 |
7
🐜
|
|
🐜
|
Mortality and causes of death of 513 Danish patients with systemic lupus erythematosus.
13 auth.
Søren Jacobsen,
J. Petersen,
S. Ullman,
P. Junker,
Anne Voss,
Rasmussen Jm,
U. Tarp,
L. Poulsen,
G. V. O. Hansen,
B. Skaarup,
...
Hansen Tm,
J. Pødenphant,
P. Halberg
|
7 |
1999 |
7
🐜
|
|
🐜
|
Clinical response, drug survival and predictors thereof in 432 ankylosing spondylitis patients after switching tumour necrosis factor α inhibitor therapy: results from the Danish nationwide DANBIO registry
16 auth.
B. Glintborg,
M. Østergaard,
N. Krogh,
U. Tarp,
N. Manilo,
A. Loft,
A. Hansen,
A. Schlemmer,
V. Fana,
H. Lindegaard,
...
H. Nordin,
C. Rasmussen,
L. Ejstrup,
D. Jensen,
P. M. Petersen,
M. Hetland
|
7 |
2012 |
7
🐜
|
|
🐜
|
A multicentre study of 513 Danish patients with systemic lupus erythematosus. I. Disease manifestations and analyses of clinical subsets
13 auth.
Søren Jacobsen,
J. Petersen,
S. Ullman,
Peter Junker,
Anne Voss,
Rasmussen Jm,
U. Tarp,
L. Poulsen,
G. V. O. Hansen,
B. Skaarup,
...
T. M. Hansen,
J. Pødenphant,
P. Halberg
|
7 |
2005 |
7
🐜
|
